Skip to Main Content
Volastra
Menu Button
About
Pipeline
Team
Join
News
Contact
News
Oncology specialist Volastra brings in PhI drug from Amgen, nabs $60M in Series A
March 16, 2023
SEE ALL NEWS STORIES